Susquehanna Ireland Ltd Form 8.3 - Takeda Pharmaceutical Company Limited (5324M)
08 Enero 2019 - 6:31AM
UK Regulatory
TIDMSHP TIDM0RN3
RNS Number : 5324M
Susquehanna Ireland Ltd
08 January 2019
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Susquehanna International Holdings LLC ("SIHLLC")
(b) Owner or controller of interests and short positions n/a
disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a
trust, the trustee(s),
settlor and beneficiaries must be named.
--------------------------------------------------
(c) Name of offeror/offeree in relation to whose relevant Takeda Pharmaceutical Company Ltd
securities this form relates:
Use a separate form for each offeror/offeree
--------------------------------------------------
(d) If an exempt fund manager connected with an offeror/offeree, n/a
state this and specify identity
of offeror/offeree:
--------------------------------------------------
(e) Date position held/dealing undertaken: 07/01/2019
For an opening position disclosure, state the latest practicable
date prior to the disclosure
--------------------------------------------------
(f) In addition to the company in 1(c) above, is the discloser YES -Shire Plc
making disclosures in respect
of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
--------------------------------------------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security: Ordinary Stock ISIN: JP3463000004
ISIN: US8740602052
Interests Short positions
-------------- ------------------------
Number % Number %
---------- -------------- --------
(1) Relevant securities owned and/or controlled: 0
---------- -------------- --------
(2) Cash-settled derivatives: 0 (5,297,800) -0.68%
---------- -------------- --------
(3) Stock-settled derivatives (including options) and agreements to
purchase/sell:
---------- -------------- --------
TOTAL: 0 (5,297,800) -0.68%
---------- -------------- --------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit (JPY)
ORDINARY PURCHASE 1500 4031
--------------- --------------------- ---------------------
ORDINARY PURCHASE 900 4047
--------------- --------------------- ---------------------
ORDINARY PURCHASE 1600 3915
--------------- --------------------- ---------------------
ORDINARY PURCHASE 2600 3915
--------------- --------------------- ---------------------
ORDINARY PURCHASE 1000 3915
--------------- --------------------- ---------------------
ORDINARY PURCHASE 200 3918
--------------- --------------------- ---------------------
ORDINARY PURCHASE 100 3931
--------------- --------------------- ---------------------
ORDINARY PURCHASE 100 3955.5
--------------- --------------------- ---------------------
ORDINARY PURCHASE 200 3961.5
--------------- --------------------- ---------------------
ORDINARY PURCHASE 200 3980.5
--------------- --------------------- ---------------------
ORDINARY PURCHASE 200 3989.5
--------------- --------------------- ---------------------
ORDINARY PURCHASE 100 3994.5
--------------- --------------------- ---------------------
ORDINARY PURCHASE 100 3994.5
--------------- --------------------- ---------------------
ORDINARY SALE -400 4034
--------------- --------------------- ---------------------
ORDINARY SALE -100 4071
--------------- --------------------- ---------------------
ORDINARY SALE -600 4070
--------------- --------------------- ---------------------
ORDINARY SALE -400 4065
--------------- --------------------- ---------------------
ORDINARY SALE -300 4032
--------------- --------------------- ---------------------
ORDINARY SALE -600 4031
--------------- --------------------- ---------------------
ORDINARY SALE -100 3958
--------------- --------------------- ---------------------
ORDINARY SALE -500 3957
--------------- --------------------- ---------------------
ORDINARY SALE -200 3960
--------------- --------------------- ---------------------
ORDINARY SALE -100 3959
--------------- --------------------- ---------------------
ORDINARY SALE -100 3959
--------------- --------------------- ---------------------
ORDINARY SALE -100 3959
--------------- --------------------- ---------------------
ORDINARY SALE -400 3983
--------------- --------------------- ---------------------
ORDINARY SALE -900 3983
--------------- --------------------- ---------------------
ORDINARY SALE -600 3982
--------------- --------------------- ---------------------
ORDINARY SALE -400 3981
--------------- --------------------- ---------------------
ORDINARY SALE -800 3980
--------------- --------------------- ---------------------
ORDINARY SALE -200 3981
--------------- --------------------- ---------------------
ORDINARY SALE -1800 3991
--------------- --------------------- ---------------------
ORDINARY SALE -200 3994
--------------- --------------------- ---------------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
CFD (on ordinary shares) CFD Increasing a short 150,000 3987.9853 JPY
position
-------------------- ------------------------- ------------------------- ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit
relates etc.
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the person making the disclosure and any party to the offer or
any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person
making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 08/01/2019
Contact name: Diana Taraseviciute / Damian Kenny
-----------------------------------
+353-1-247-8480
Telephone number*: + 353-1-802-8089
-----------------------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does
not need to be included, provided contact information has been
provided to the Panel's Market Surveillance Unit.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RETUGURPGUPBGPR
(END) Dow Jones Newswires
January 08, 2019 07:31 ET (12:31 GMT)
Shire (LSE:SHP)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Shire (LSE:SHP)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
